APA

Igarashi H., Taniguchi H., Nosho K., Ishigami K., Koide H., Mitsuhashi K., Okita K., Takemasa I., Imai K. & Nakase H. (20210325). PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Chicago

Igarashi H, Taniguchi H, Nosho K, Ishigami K, Koide H, Mitsuhashi K, Okita K, Takemasa I, Imai K and Nakase H. 20210325. PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Harvard

Igarashi H., Taniguchi H., Nosho K., Ishigami K., Koide H., Mitsuhashi K., Okita K., Takemasa I., Imai K. and Nakase H. (20210325). PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

MLA

Igarashi H, Taniguchi H, Nosho K, Ishigami K, Koide H, Mitsuhashi K, Okita K, Takemasa I, Imai K and Nakase H. PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 20210325.